Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Significance of Radical Surgery in the Treatment of Silent Corticotroph Adenoma

  • Kim, Junhyung (Department of Neurosurgery, Yonsei University College of Medicine) ;
  • Yoon, Seon Jin (Department of Neurosurgery, Yonsei University College of Medicine) ;
  • Moon, Ju Hyung (Department of Neurosurgery, Yonsei University College of Medicine) ;
  • Ku, Cheol Ryong (Endocrine Research Institute, Yonsei University College of Medicine) ;
  • Kim, Se Hoon (Pituitary Tumor Center, Severance Hospital) ;
  • Lee, Eun Jig (Endocrine Research Institute, Yonsei University College of Medicine) ;
  • Kim, Sun Ho (Department of Neurosurgery, Yonsei University College of Medicine) ;
  • Kim, Eui Hyun (Department of Neurosurgery, Yonsei University College of Medicine)
  • Received : 2018.01.31
  • Accepted : 2018.04.29
  • Published : 2019.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : Silent corticotroph adenomas (SCA) are endocrine-inactive pituitary adenomas with positive immunohistochemistry staining for adrenocorticotropic hormone (ACTH). We investigated whether SCA-associated clinical profiles were more aggressive than hormonally negative adenomas (HNA). Methods : Among 627 patients with pathologically proven endocrine-inactive pituitary adenomas between 2004 and 2013, positive immunohistochemistry revealed 55 SCAs and 411 HNAs. Surgical outcomes and radiological and endocrinological characteristics were compared. Results : Strong female predominance was observed in the SCA group (p<0.001). Cavernous sinus invasion was identified in 22 (40%) SCA patients and 72 (17.6%) HNA patients (p<0.001). There were no differences in ACTH or cortisol levels between the two groups. The incidence of preoperative hypopituitarism and postoperative hormonal outcome did not differ between two groups. Total resection was achieved in 35 patients (63.7%) with SCA and 332 patients (80.8%) with HNA (p=0.007). When tumors were completely removed, recurrence rates were not statistically different between two groups (p=0.60). When complete resection was not achieved, tumors regrew from these remnants in seven patients (35.0%) with SCA and 12 patients (15.2%) with HNA (p=0.05). Conclusion : Total surgical resection for SCA is often challenging as these tumors frequently invade a cavernous sinus. Early remnant tumor intervention is justified, because untreated residual pituitary tumors regrow when patients were followed up for a long time. Prophylactic radiotherapy is not warranted for completely resected SCAs as tumor recurrence is uncommon.

Keywords

References

  1. Alahmadi H, Lee D, Wilson JR, Hayhurst C, Mete O, Gentili F, et al. : Clinical features of silent corticotroph adenomas. Acta Neurochir (Wien) 154 : 1493-1498, 2012 https://doi.org/10.1007/s00701-012-1378-1
  2. Baldeweg SE, Pollock JR, Powell M, Ahlquist J : A spectrum of behaviour in silent corticotroph pituitary adenomas. Br J Neurosurg 19 : 38-42, 2005 https://doi.org/10.1080/02688690500081230
  3. Bradley KJ, Wass JAH, Turner HE : Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently. Clin Endocrinol (Oxf) 58 : 59-64, 2003 https://doi.org/10.1046/j.1365-2265.2003.01674.x
  4. Cho HY, Cho SW, Kim SW, Shin CS, Park KS, Kim SY : Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas. Clin Endocrinol (Oxf) 72 : 648- 653, 2010 https://doi.org/10.1111/j.1365-2265.2009.03673.x
  5. Horvath E, Kovacs K, Killinger DW, Smyth HS, Platts ME, Singer W : Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study. Am J Pathol 98 : 617-638, 1980
  6. Ioachimescu AG, Eiland L, Chhabra VS, Mastrogianakis GM, Schniederjan MJ, Brat D, et al. : Silent corticotroph adenomas: Emory University cohort and comparison with ACTH-negative nonfunctioning pituitary adenomas. Neurosurgery 71 : 296-303; discussion 304, 2012 https://doi.org/10.1227/NEU.0b013e318257c1f0
  7. Jahangiri A, Wagner JR, Pekmezci M, Hiniker A, Chang EF, Kunwar S, et al. : A comprehensive long-term retrospective analysis of silent corticotrophic adenomas vs hormone-negative adenomas. Neurosurgery 73 : 8-17; discussion 17-18, 2013 https://doi.org/10.1227/01.neu.0000429858.96652.1e
  8. Kim EH, Ku CR, Lee EJ, Kim SH : Extracapsular en bloc resection in pituitary adenoma surgery. Pituitary 18 : 397-404, 2015 https://doi.org/10.1007/s11102-014-0587-4
  9. Ku CR, Kim EH, Oh MC, Lee EJ, Kim SH : Surgical and endocrinological outcomes in the treatment of growth hormone-secreting pituitary adenomas according to the shift of surgical paradigm. Neurosurgery 71(2 Suppl Operative) : ons192-ons203; discussion ons203, 2012
  10. Lee EJ, Ahn JY, Noh T, Kim SH, Kim TS, Kim SH : Tumor tissue identification in the pseudocapsule of pituitary adenoma: should the pseudocapsule be removed for total resection of pituitary adenoma? Neurosurgery 64 : ons62-ons69; discussion ons69-ons70, 2009
  11. Lillehei KO, Kirschman DL, Kleinschmidt-DeMasters BK, Ridgway EC : Reassessment of the Role of Radiation Therapy in the Treatment of Endocrine-inactive Pituitary Macroadenomas. Neurosurgery 43 : 432- 438; discussion 438-439, 1998 https://doi.org/10.1097/00006123-199809000-00020
  12. Pawlikowski M, Kunert-Radek J, Radek M : "Silent"corticotropinoma. Neuro Endocrinol Lett 29 : 347-350, 2008
  13. Scheithauer BW, Jaap AJ, Horvath E, Kovacs K, Lloyd RV, Meyer FB, et al. : Clinically silent corticotroph tumors of the pituitary gland. Neurosurgery 47 : 723-729; discussion 729-730, 2000 https://doi.org/10.1227/00006123-200009000-00039
  14. Webb KM, Laurent JJ, Okonkwo DO, Lopes MB, Vance ML, Laws ER Jr : Clinical characteristics of silent corticotrophic adenomas and creation of an internet-accessible database to facilitate their multi-institutional study. Neurosurgery 53 : 1076-1084; discussion 1084-1075, 2003 https://doi.org/10.1227/01.NEU.0000088660.16904.F7
  15. Xu Z, Ellis S, Lee CC, Starke RM, Schlesinger D, Lee Vance M, et al. : Silent corticotroph adenomas after stereotactic radiosurgery: a casecontrol study. Int J Radiat Oncol Biol Phys 90 : 903-910, 2014 https://doi.org/10.1016/j.ijrobp.2014.07.013

Cited by

  1. Silent corticotroph adenomas: Experience with five cases vol.156, pp.11, 2019, https://doi.org/10.1016/j.medcle.2020.02.016
  2. An Update on Silent Corticotroph Adenomas: Diagnosis, Mechanisms, Clinical Features, and Management vol.13, pp.23, 2019, https://doi.org/10.3390/cancers13236134